Literature DB >> 7479655

3'-Deoxy-3'-fluoroinosine as a potent antileishmanial agent. The metabolism and selective cytotoxic effect of 3'-deoxy-3'-fluoroinosine against Leishmania tropica and L. donovani in vitro and in vivo.

I S Shin1, H Tanifuji, Y Arata, Y Morizawa, T Nakayama, Y Wataya.   

Abstract

We studied the antileishmanial activity of 3'-deoxy-3'-fluoroinosine (3'-FI) against Leishmania tropica and L. donovani. In in vitro cultivation, the EC50 values (the concentration of drug necessary to inhibit the growth rate of cells to 50% of the control value) obtained for 3'-FI against the promastigotes of L. tropica and L. donovani were 2.3 x 10(-7) and 1.0 x 10(-6) M, respectively. It was less toxic toward mouse mammary-tumor FM3A cells, a model host; the EC50 value was 1.9 x 10(-4) M. Leishmania promastigote metabolized 3'-FI to 3'-deoxy-3'-fluoroadenosine 5'-triphosphate (3'-FATP) but FM3A cells did not. 3'-FI was effective against L. donovani amastigotes in J774.1 cells in an in vitro cultivation system under conditions similar to those used in the in vivo assay. 3'-FI (50 mg/kg, given i.v.) showed a cytotoxic effect against the amastigotes of L. donovani in mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479655     DOI: 10.1007/bf00932030

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  20 in total

1.  Harmful effect of high stibogluconate treatment of kala-azar in India.

Authors:  C P Thakur
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

2.  Nucleosidases from Leishmania donovani. Pyrimidine ribonucleosidase, purine ribonucleosidase, and a novel purine 2'-deoxyribonucleosidase.

Authors:  G W Koszalka; T A Krenitsky
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

3.  Biological action of inosine analogs in Leishmania and Trypanosoma spp.

Authors:  J J Marr; R L Berens; N K Cohn; D J Nelson; R S Klein
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

4.  Phosphorylation and anti-leishmanial activity of formycin B.

Authors:  D A Carson; K P Chang
Journal:  Biochem Biophys Res Commun       Date:  1981-06-16       Impact factor: 3.575

5.  Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.

Authors:  A D Bryceson; J D Chulay; M Mugambi; J B Were; G Gachihi; C N Chunge; R Muigai; S M Bhatt; M Ho; H C Spencer
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

6.  Metabolism and mechanism of action of formycin B in Leishmania.

Authors:  P Rainey; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  Inosine analogs. Their metabolism in mouse L cells and in Leishmania donovani.

Authors:  S W LaFon; D J Nelson; R L Berens; J J Marr
Journal:  J Biol Chem       Date:  1985-08-15       Impact factor: 5.157

Review 8.  Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.

Authors:  J D Berman
Journal:  Rev Infect Dis       Date:  1988 May-Jun

9.  Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice.

Authors:  D J Bradley; J Kirkley
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

10.  Carbocyclic inosine as a potent anti-leishmanial agent: the metabolism and selective cytotoxic effects of carbocyclic inosine in promastigotes of Leishmania tropica and Leishmania donovani.

Authors:  O Hiraoka; H Satake; S Iguchi; A Matsuda; T Ueda; Y Wataya
Journal:  Biochem Biophys Res Commun       Date:  1986-02-13       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.